Lataa...
The novel, small molecule DNA methylation inhibitor SGI-110 as an ovarian cancer chemosensitizer
PURPOSE: To investigate SGI-110 as a “chemosensitizer” in ovarian cancer (OC) and to assess its effects on tumor suppressor genes (TSG) and chemo-responsiveness associated genes silenced by DNA methylation in OC. EXPERIMENTAL DESIGN: Several OC cell lines were used for in vitro and in vivo platinum...
Tallennettuna:
Julkaisussa: | Clin Cancer Res |
---|---|
Päätekijät: | , , , , , , , , , , , , , , , |
Aineistotyyppi: | Artigo |
Kieli: | Inglês |
Julkaistu: |
2014
|
Aiheet: | |
Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4268357/ https://ncbi.nlm.nih.gov/pubmed/25316809 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1553 |
Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|